PAM
JANX icon

Panagora Asset Management’s Janux Therapeutics JANX Stock Holding History

Panagora Asset Management’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.13M Buy
+269,113
New +$3.9M 0.01% 483

Other funds holding JANX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AC
AXQ Capital Jersey City, New Jersey $920M AUM 18.71% 1-Year Est. Return

Panagora Asset Management's JANX Position: Q2 2026 in Review

Panagora Asset Management opened a new position in Janux Therapeutics (JANX) in Q2 2026: 269,113 shares worth $4.13M. The stake represents 0.01% of the portfolio and ranks #483 among its holdings.

48 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Panagora Asset Management held 269,113 shares of Janux Therapeutics worth $4.13M as of Q2 2026.
  • Janux Therapeutics was a new Panagora Asset Management position in Q2 2026.
  • Janux Therapeutics made up 0.01% of Panagora Asset Management's portfolio in Q2 2026, its #483 holding.
  • 48 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.